Ken Fisher
PACB icon

Ken Fisher’s Pacific Biosciences PACB Stock Holding History

Ken Fisher’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-55,432
Closed -$101K – 1049
2024
Q4 		$101K Buy
55,432
+550
+1% +$1.07K ﹤0.01% 961
2024
Q3 		$93.3K Sell
54,882
-1,190
-2% -$1.96K ﹤0.01% 912
2024
Q2 		$76.8K Buy
56,072
+1,090
+2% +$2.2K ﹤0.01% 967
2024
Q1 		$206K Buy
54,982
+28
+0.1% +$164 ﹤0.01% 937
2023
Q4 		$539K Buy
54,954
+72
+0.1% +$589 ﹤0.01% 766
2023
Q3 		$458K Hold
54,882
– – ﹤0.01% 858
2023
Q2 		$730K Hold
54,882
– – ﹤0.01% 827
2023
Q1 		$636K Hold
54,882
– – ﹤0.01% 824
2022
Q4 		$449K Hold
54,882
– – ﹤0.01% 849
2022
Q3 		$319K Hold
54,882
– – ﹤0.01% 816
2022
Q2 		$243K Hold
54,882
– – ﹤0.01% 840
2022
Q1 		$499K Sell
54,882
-10
-0% -$115 ﹤0.01% 730
2021
Q4 		$1.12M Buy
54,892
+6,043
+12% +$146K ﹤0.01% 623
2021
Q3 		$1.25M Buy
48,849
+13,437
+38% +$398K ﹤0.01% 582
2021
Q2 		$1.24M Sell
35,412
-23,244
-40% -$676K ﹤0.01% 584
2021
Q1 		$1.95M Buy
58,656
+1,282
+2% +$44.9K ﹤0.01% 540
2020
Q4 		$1.49M Sell
57,374
-21,177
-27% -$360K ﹤0.01% 551
2020
Q3 		$775K Buy
+78,551
New +$452K ﹤0.01% 594

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ken Fisher's PACB Position: Q1 2025 in Review

Ken Fisher sold out of Pacific Biosciences (PACB) in Q1 2025, closing a stake of 55,432 shares — an estimated $101K sold.

Ken Fisher first reported a position in PACB in Q3 2020 and held it in 18 quarters. The position peaked at $1.95M in Q1 2021. 225 funds tracked by Wall St. Rank hold PACB as of Q1 2025.

  • Ken Fisher reported no remaining Pacific Biosciences position as of Q1 2025 after selling out during the quarter.
  • Ken Fisher sold 55,432 Pacific Biosciences shares in Q1 2025, an estimated $101K.
  • Ken Fisher first reported a position in Pacific Biosciences in Q3 2020 and held it in 18 quarters.
  • Ken Fisher's Pacific Biosciences position peaked at $1.95M in Q1 2021.
  • 225 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2025.

Based on Fisher Asset Management's 13F filing for Q1 2025, filed 14 May 2025.